| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,167 |
1,896 |
$76K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
635 |
581 |
$42K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
223 |
192 |
$23K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
500 |
457 |
$23K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
223 |
207 |
$12K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
119 |
106 |
$5K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
103 |
100 |
$5K |
| 71046 |
Radiologic examination, chest; 2 views |
99 |
92 |
$3K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
45 |
41 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
83 |
78 |
$2K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
27 |
26 |
$1K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
12 |
12 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
64 |
60 |
$765.07 |
| 71020 |
|
20 |
19 |
$748.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
15 |
13 |
$667.29 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
57 |
53 |
$527.20 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
14 |
12 |
$497.53 |
| 90656 |
|
35 |
35 |
$478.95 |
| 90648 |
|
12 |
12 |
$185.40 |
| 90677 |
|
12 |
12 |
$157.68 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
136 |
127 |
$70.27 |
| 3008F |
|
377 |
350 |
$0.00 |
| 1000F |
|
26 |
26 |
$0.00 |
| 96160 |
|
47 |
39 |
$0.00 |
| 2014F |
|
145 |
126 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
34 |
31 |
$0.00 |